Ingrediente speciale
β-NMN Powder Manufacturer & Supplier
β-Nicotinamide Mononucleotide (β-NMN) is supplied as a fine NMN powder for supplement formulation and commercial ingredient supply. Technical specifications, representative batch data, packaging and storage information support material evaluation and purchasing decisions.
Product Information
β-Nicotinamide Mononucleotide Powder
Key identity and supply characteristics for β-NMN powder used in supplement product development.
Product Overview
Technical Considerations for NMN Powder
NMN powder should be evaluated as a complete raw material rather than by a single headline value. Analytical basis, physical behavior and control parameters each affect qualification for a finished formulation.
Analytical Basis
Assay on an anhydrous basis and chromatographic area purity describe different analytical characteristics. Keeping those measures separate gives formulators and quality teams a clearer basis for comparing NMN raw-material specifications.
Qualification Scope
Raw-material review also considers residual substances, elemental contaminants and microbiological controls. These parameters help quality teams assess whether a material specification is appropriate for the intended dosage form and destination market.
Product Batch
Representative Production Batch
Specifiche tecniche
β-NMN Specification & COA Results
Representative batch results are presented alongside the corresponding specification and test method for technical review.
| Test Item | Specifiche | Test Method | Result |
|---|---|---|---|
| Descrizione | |||
| Aspetto | Pure white fine powder | Visivo | Complies |
| Odore | Caratteristica | Sensory | Complies |
| Il gusto | Caratteristica | Sensory | Complies |
| Perdita all'essiccazione | ≤ 1.0% | 2g/105℃/5hrs | 0.12% |
| Densità della massa | / | W/V | 0.64 g/ml |
| pH (1mg/1ml water) | 2.0 - 4.0 | pH meter | 3.4 |
| Analisi | |||
| Assay (on the anhydrous basis) | ≥ 98% | HPLC | 99.20% |
| Purity (area%) | ≥ 99.5% | HPLC | 99.90% |
| Sostanze contaminanti | |||
| Metalli pesanti | ≤ 10 ppm | Colorimetric method | Complies |
| Arsenic (As) | ≤ 0.5 ppm | AFS | Complies |
| Lead (Pb) | ≤ 0.5 ppm | AFS | Complies |
| Cadmium (Cd) | ≤ 0.1 ppm | AFS | Complies |
| Mercurio (Hg) | ≤ 0.1 ppm | AFS | Complies |
| Na+ Residue | ≤ 1.0% | IC | Complies |
| Pesticides Residues | Meet USP | LC-MSMS/GC-MS | Complies |
| Ethanol | ≤ 5000 ppm | GC | Complies |
| Microbiological | |||
| Total microbacterial count | ≤ 1000 CFU/g | GB 4789.2 | Complies |
| Yeast | ≤ 100 CFU/g | GB 4789.15 | Complies |
| Mold | ≤ 100 CFU/g | GB 4789.15 | Complies |
| E. Coli | Negativo | GB 4789.38 | Negativo |
| Salmonella | Negativo | GB 4789.4 | Negativo |
Application Areas
Where β-NMN Fits in Product Development
As a fine powder, β-NMN can be considered across several solid supplement formats. Processing behavior, excipient system, stability strategy and market requirements should be assessed during formulation development.
Capsule
Powder handling and bulk density are relevant when assessing capsule fill performance and finished-product manufacturing requirements.
Compresse
Tablet development should account for the complete formulation system, including flow, compression behavior, excipient compatibility and the processing conditions selected for the finished product.
Powder Formats
Powder blends and stick-style formats can be evaluated against material properties, stability needs and the intended finished-product process.
Premix personalizzati
For multi-ingredient systems, compatibility, blend uniformity and the contribution of each component to the finished dosage form can be considered before pilot-scale work.
Ingredient Review
From Sample Review to Commercial Supply
Moving from initial evaluation to commercial purchasing requires alignment between the formulation, quality documentation, packaging configuration and order requirements.
Commercial Qualification Path
A practical qualification process connects laboratory evaluation with the information needed for purchasing and production planning.
Research Context
NMN has been investigated in randomized human studies in relation to NAD+ metabolism. Reported findings differ across study populations, intervention designs and measured endpoints, so published research should be interpreted in its specific study context.
Imballaggio
25 kg / Drum
The supplied COA specifies paper drums with two food-grade poly bags inside. Net weight is 25 kg per drum.
Immagazzinamento
Cool & Dry Conditions
- Seal the package and keep the material in a cool, dry place.
- Avoid direct sunlight during storage.
- Shelf life is 24 months under the stated conditions and original packaging.
Documentazione
Information for Material Qualification
Documentation requirements can vary by customer, application and destination market. Available project information can be aligned with the material review before commercial ordering.
Certificate of Analysis
Representative batch testing provides a reference for comparing the ordered material with the agreed technical specification.
Specification Review
Use the agreed specification as the technical reference for raw-material approval, incoming quality review and purchasing alignment.
Sample Coordination
Coordinate evaluation material with the intended dosage form and development stage so testing can focus on the requirements relevant to the project.
Ingredient Supply Inquiry
Discuss Your β-NMN Powder Requirements
Share the key details of your project so technical and commercial information can be matched to your evaluation and purchasing requirements.
Quantity & Destination
Provide the expected order quantity and destination market so commercial supply requirements can be reviewed.
Application & Development Stage
Share the intended dosage form and whether the project is in evaluation, pilot development or commercial purchasing.
Documents & Quotation
Identify the technical documents, packaging information and quotation details needed for your procurement process.